Senescence is a multifactorial process, which appears to be associated with increases in both oxidative and inflammatory events. The ability to slow or reverse changes associated with brain aging by dietary supplementation will be investigated with a focus on these two processes. Following an initial survey of a broad range of agents, melatonin has been selected for detailed study. Changes in gene expression following treatment of aged mice with melatonin will be evaluated using array technology in combination with Northern blotting. Investigation of those genes associated with inflammatory or pro-oxidant events will be emphasized. The cytosolic pathways leading to genomic modulation will be sought. Levels of proteins potentially affected by altered mRNA levels will be quantitated using ELISA and Western assays. The ability of melatonin to restore integrity of mitochondrial functioning and retard age-related mitochondrial DNA deletion will be evaluated. Immunohistochemical identification of specific peptides from fixed tissue sections will allow a more precise localization of any changes observed. Arrest or reversal of trends associated with age will be evaluated by comparison of patterns of mRNA and proteins from dosed mice with those from younger animals. Parallel studies using behavioral endpoints will reveal whether molecular changes detected, are reflected by altered cognition or motor strength. The degree of consonance between biological and behavioral changes may imply a causal relation. Results will contribute to development of a rational strategy for delaying progression of brain aging. This is also likely to be relevant to slowing the onset of, and reducing the incidence of, several neurodegenerative diseases where age is a major co-factor. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG016794-09
Application #
7232281
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Wise, Bradley C
Project Start
1999-04-01
Project End
2009-03-31
Budget Start
2007-05-01
Budget End
2008-03-31
Support Year
9
Fiscal Year
2007
Total Cost
$282,379
Indirect Cost
Name
University of California Irvine
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Sharman, Edward H; Sharman, Kaizhi G; Bondy, Stephen C (2011) Extended exposure to dietary melatonin reduces tumor number and size in aged male mice. Exp Gerontol 46:18-22
Sharman, Edward H; Sharman, Kaizhi G; Bondy, Stephen C (2008) Melatonin causes gene expression in aged animals to respond to inflammatory stimuli in a manner differing from that of young animals. Curr Aging Sci 1:152-8
Kleinman, M T; Araujo, J A; Nel, A et al. (2008) Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways. Toxicol Lett 178:127-30
Li, H; Campbell, A; Ali, S F et al. (2007) Chronic exposure to low levels of aluminum alters cerebral cell signaling in response to acute MPTP administration. Toxicol Ind Health 23:515-24
Sharman, Edward H; Bondy, Stephen C; Sharman, Kaizhi G et al. (2007) Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. Neurochem Int 50:336-44
Perreau, V M; Bondy, S C; Cotman, C W et al. (2007) Melatonin treatment in old mice enables a more youthful response to LPS in the brain. J Neuroimmunol 182:22-31
HaMai, Diem; Rinderknecht, Amber L; Guo-Sharman, Kaizhi et al. (2006) Decreased expression of inflammation-related genes following inhalation exposure to manganese. Neurotoxicology 27:395-401
Becaria, Angelica; Lahiri, Debomoy K; Bondy, Stephen C et al. (2006) Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J Neuroimmunol 176:16-23
Campbell, Arezoo (2006) The role of aluminum and copper on neuroinflammation and Alzheimer's disease. J Alzheimers Dis 10:165-72
Bondy, Stephen C; Campbell, Arezoo (2005) Developmental neurotoxicology. J Neurosci Res 81:605-12

Showing the most recent 10 out of 37 publications